accountby drug maker GlaxoSmithKline and the PATH Malaria Vaccine Initiative, which is funded by the Bill & Melinda Gates Foundation. The Phase III testing is being done at 11 sites in seven African countries on 16,000 children under the age of 18 months. The...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to New vaccine offers hope in Africa's malaria battle
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
